Document Detail


Discovery of a role for Hsp82 in Histoplasma virulence through a quantitative screen for macrophage lethality.
MedLine Citation:
PMID:  21606189     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The application of forward genetics can reveal new factors required for the virulence of intracellular pathogens. To facilitate such virulence screens, we developed macrophage cell lines with which the number of intact host cells following infection with intracellular pathogens can be rapidly and easily ascertained through the expression of a constitutive lacZ transgene. Using known virulence mutants of Francisella novicida and Histoplasma capsulatum, we confirmed the applicability of these host cells for the quantitative assessment of bacterial and fungal virulence, respectively. To identify new genes required for Histoplasma virulence, we employed these transgenic macrophage cells to screen a collection of individual transfer DNA (T-DNA) insertion mutants. Among the mutants showing decreased virulence in macrophages, we identified an insertion in the locus encoding the Histoplasma Hsp82 homolog. The lesion caused by the T-DNA insertion localizes to the promoter region, resulting in significantly decreased HSP82 expression. Reduced HSP82 expression markedly attenuates the virulence of Histoplasma yeast in vivo. While the HSP82 hypomorph grows normally in vitro at 37°C and under acid and salinity stresses, its ability to recover from high-temperature stress is impaired. These results provide genetic proof of the role of stress chaperones in the virulence of a thermally dimorphic fungal pathogen.
Authors:
Jessica A Edwards; Olga Zemska; Chad A Rappleye
Related Documents :
11673659 - Cytokine levels in various intravenous immunoglobulin (ivig) preparations.
21208809 - Association of macrophage migration inhibitory factor (mif) polymorphisms with risk of ...
8982979 - An approach to study molecular mechanisms involved in cytokine-induced anorexia.
7926369 - Cytokine production by epithelial cells.
16140389 - Veterinary applications of cytokines.
8587839 - Cytokines in the treatment of malignancies.
19995569 - Tumor cell redox state and mitochondria at the center of the non-canonical activity of ...
8155999 - Eosinophil chemiluminescence response to cytokines and opsonized zymosans in atopic der...
16804709 - Correlation between bax overexpression and prion deposition in medulla oblongata from n...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-05-23
Journal Detail:
Title:  Infection and immunity     Volume:  79     ISSN:  1098-5522     ISO Abbreviation:  Infect. Immun.     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-18     Completed Date:  2011-09-13     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  0246127     Medline TA:  Infect Immun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3348-57     Citation Subset:  IM    
Affiliation:
Department of Microbiology, The Center for Microbial Interface Biology, Ohio State University, Columbus, OH 43210, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Biological Assay / methods
Cell Death*
Francisella tularensis / genetics,  pathogenicity
Genes, Reporter
Histoplasma / genetics,  pathogenicity*
Macrophages / immunology*,  microbiology*
Mice
Mice, Inbred C57BL
Mutagenesis, Insertional
Virulence
beta-Galactosidase / metabolism
Grant Support
ID/Acronym/Agency:
AI083335/AI/NIAID NIH HHS; R01 AI083335/AI/NIAID NIH HHS; R01 AI083335-02/AI/NIAID NIH HHS; R01 AI083335-03/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
EC 3.2.1.23/beta-Galactosidase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mycobacterium tuberculosis culture filtrate protein 10-specific effector/memory CD4? and CD8? T cell...
Next Document:  Non-glycemic effects of insulin-therapy: A comparison between insulin aspart and regular human insul...